OS Therapies Inc 8-K

What Happened
OS Therapies Inc. (OSTX) announced that on January 10, 2026 it entered into inducement offer letter agreements with fewer than 10 accredited investors who hold certain existing warrants. The holders agreed to exercise (or pre-fund the exercise of) those existing warrants at a reduced exercise price of $1.40 per share (or $1.399 per share for pre-funding). In return, the company agreed to issue new common stock purchase warrants to purchase up to an aggregate of 5,382,148 shares at an exercise price of $1.40. The company extended the inducement offering period from its original February 10, 2026 expiration to 11:59 p.m. Eastern on March 2, 2026.

Key Details

• Inducement agreements entered: January 10, 2026, with fewer than 10 accredited investors.
• Aggregate shares covered: up to 5,382,148 common shares.
• Exercise price: $1.40 per share (or $1.399 per share for pre-funding).
• Offering period extended from Feb 10, 2026 to March 2, 2026.

Why It Matters
This transaction could produce immediate cash for the company if the holders exercise their existing warrants at the reduced price and may lead to future dilution if the newly issued warrants are later exercised. If all 5,382,148 existing warrants are exercised at $1.40, the company would receive roughly $7.5 million in proceeds (5,382,148 × $1.40). Investors should watch subsequent filings for confirmations of exercises, issuance of the new warrants, and any changes to outstanding share count.